← Leaderboards
Sundaram Ramakrishnan
University Of Minnesota
$4,051,104
Attributed
$7,052,740
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $956K · FY2007–22$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$7,052,740 · 6
By mechanism
R01$7,052,740 · 6
Top collaborators
- Sabita Roy11 shared
- Shuanglin Hao5 shared
- Eli Gilboa3 shared
Most similar at University Of Minnesota
Same institution · by research overlap
- Dezhi Liao$5,861,824
- Douglas Yee$35,505,227
- Matthew Carl Hearing$4,781,466
- Patrick Rothwell$8,678,718
- Sulagna Banerjee$1,586,339
Others in their field
Top investigators on “Base”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$613,567,095
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$521,411,998
- Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$507,042,060
Research focus
BaseMediatingIn VivoPreventSignal TransductionMorphineAffectReportingChronicOpioidResponseAttenuatedSiteBacterial TranslocationProteinsSerumIn VitroHiv InfectionsPathway InteractionsPharmaceutical PreparationsNon-DrugHiv-1GrowthCancer Cell
Grant awards (21)
Role of Gut Microbiome in HIV/Opioid Induced Peripheral Neuropathy$464,517
R01 · FY2022 · DA
Role of HSP70 in Pancreatic Diseases$321,544
R01 · FY2022 · CA · contact PI
Role of Gut Microbiome in HIV/Opioid Induced Peripheral Neuropathy$464,518
R01 · FY2021 · DA
Role of HSP70 in Pancreatic Diseases$328,106
R01 · FY2021 · CA · contact PI
Role of Gut Microbiome- Brain Axis in Modulating CNS Inflammasomes in the Neuropathology Produced by Opioid Exposure and HIV$153,500
R01 · FY2021 · DA
Role of Gut Microbiome in HIV/Opioid Induced Peripheral Neuropathy$464,517
R01 · FY2020 · DA
Role of HSP70 in Pancreatic Diseases$423,276
R01 · FY2020 · CA · contact PI
Evaluation of Deleterious Effects of Opioids in Pancreatitis$491,512
R01 · FY2019 · DK · contact PI
Role of Gut Microbiome in HIV/Opioid Induced Peripheral Neuropathy$464,518
R01 · FY2019 · DA
Role of Gut Microbiome in HIV/Opioid Induced Peripheral Neuropathy$464,517
R01 · FY2018 · DA
Role of microRNAs in opioid drug abuse induced persistent Inflammation and HIV di$334,653
R01 · FY2015 · DA
Role of microRNAs in opioid drug abuse induced persistent Inflammation and HIV di$339,750
R01 · FY2014 · DA
Role of microRNAs in opioid drug abuse induced persistent Inflammation and HIV di$326,160
R01 · FY2013 · DA
Role of microRNAs in opioid drug abuse induced persistent Inflammation and HIV di$339,750
R01 · FY2012 · DA
Role of microRNAs in opioid drug abuse induced persistent Inflammation and HIV di$339,750
R01 · FY2011 · DA
Antiangiogenic Gene Therapy of Ovarian and Breast Cancers$245,614
R01 · FY2011 · CA · contact PI
Antiangiogenic Gene Therapy of Ovarian and Breast Cancers$253,281
R01 · FY2010 · CA · contact PI
Antiangiogenic Gene Therapy of Ovarian and Breast Cancers$253,350
R01 · FY2009 · CA · contact PI
Antiangiogenic Gene Therapy of Ovarian and Breast Cancers$75,453
R01 · FY2009 · CA · contact PI
Antiangiogenic Gene Therapy of Ovarian and Breast Cancers$253,417
R01 · FY2008 · CA · contact PI
Antiangiogenic Gene Therapy of Ovarian and Breast Cancers$251,037
R01 · FY2007 · CA · contact PI